Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, K. D.
Right arrow Articles by Light, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, K. D.
Right arrow Articles by Light, R. W.
(Chest. 2004;126:1933-1937.)
© 2004 American College of Chest Physicians

Stability of Adenosine Deaminase During Transportation*

Kent D. Miller, PhD, MD; Randal Barnette, RRT, RPFT and Richard W. Light, MD, FCCP

* From Diagnostic Ventures, Inc.(Dr. Miller), Daytona Beach, FL; and the Department of Medicine (Mr. Barnette and Dr. Light), Saint Thomas Hospital and Division of Allergy, Critical Care and Pulmonary Diseases, Vanderbilt University, Nashville, TN.

Correspondence to: Richard W. Light, MD, FCCP, Director of Pulmonary Disease Program, Saint Thomas Hospital, 4220 Harding Rd, Nashville, TN 37205; e-mail: RLIGHT98{at}yahoo.com

Study objective: Measurement of pleural fluid adenosine deaminase (ADA) levels is useful in the differential diagnosis of pleural effusions. However, at ambient temperatures, the levels of this enzyme decline with time. The purpose of the present study was to identify, test, and optimize additives that stabilize ADA, consequently eliminating the need for dry ice or other cold specimen transport media.

Design: A preliminary screen of historically proven stabilizing agents for specific proteins demonstrated effectiveness of glycerol for maintenance of pleural fluid ADA levels. Systematic studies for exploitation of the glycerol effect included the following: (1) supplements to the glycerol of promising alternate compounds, (2) long-term stability studies at ambient and elevated temperatures, (3) a field test of an effective mixture as a means for reduction of specimen transport costs, (4) thermal stability studies for optimization of the agents for use at otherwise denaturing temperatures, and (5) inclusion of pleural fluids from patients with a variety of etiologies, including tuberculous pleurisy, in order to gauge the effectiveness of the stabilizing agents on both the high and low molecular weight forms of ADA.

Results: A mixture of glycerol and ethylene glycol, each at 5% concentration, maintained pleural fluid ADA levels for at least 21 days at both room temperatures and 37°C. A field test of 32 pleural fluids found that ADA levels in specimens containing this mixture, sent to the laboratory by surface mail at ambient temperatures, were nearly identical to those in aliquots of the same fluids shipped over dry ice. The bias in the measurement was 0.49 IU/L, with a precision of 2.49 IU/L. The correlation coefficient between the two measurements was 0.97. Thermal stability studies found that tuberculous pleural fluids containing 10% glycerol and 0.10 mol/L sodium sulfate maintained constant ADA levels for at least 10 days at 45°C, an otherwise denaturing temperature for nonstabilized specimens.

Conclusion: The addition of stabilizing agents to pleural fluid specimens allows the transport of those specimens to distant laboratories at ambient temperatures without a decline in the ADA levels. Employment of those agents will decrease the cost of the test and facilitate its use in second- and third-world countries.

Key Words: adenosine deaminase • pleural fluid • tuberculous pleuritis




This article has been cited by other articles:


Home page
ChestHome page
R. Laniado-Laborin
Adenosine Deaminase in the Diagnosis of Tuberculous Pleural Effusion: Is It Really an Ideal Test? A Word of Caution
Chest, February 1, 2005; 127(2): 417 - 418.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.